InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
4
已披露卖出
0
T+90 胜率
0%
T+90 平均收益
-29.9%
基于 3 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the full record of transactions filed by Sailer Carl, 董事. Insider active across 1 company, notably Acurx Pharmaceuticals, Inc.. In total, 5 disclosures have been published. Split: 4 buys · 0 sell. Total volume traded: €183k. History available since 29 June 2021. The latest transaction was disclosed on 6 January 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Sailer Carl
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报5 总计
24,631 股@ US$1.0157.3% 占其流量Common StockSEC:0001104659-25-002053:0
标准退出：2025年4月6日 (T+90)
19,737 股@ US$3.5519.4% 占其流量Common StockSEC:0001104659-24-005357:0
19,737 股@ US$3.8022.1% 占其流量Common StockSEC:0001104659-22-084317:0
标准退出：2022年10月25日 (T+90)
5,161 股@ US$4.849.0% 占其流量Common StockSEC:0001104659-21-143551:0
标准退出：2022年2月21日 (T+90)
12,500 股@ US$6.0025.5% 占其流量Common StockSEC:0001104659-21-114674:0
标准退出：2021年9月27日 (T+90)
5 条申报中的 5 条
About Sailer Carl
Carl Sailer is a Board Member at Acurx Pharmaceuticals, Inc. He plays a key role in overseeing the company's activities and making strategic decisions. Through his experience, he contributes to developing effective governance practices and achieving growth objectives. His commitment to innovation and corporate social responsibility is a valuable asset to the board.
